• Teijin, Mediridge and TFBS Bioscience to Supply Raw Materials for Regenerative Medicine Development and Manufacture

  2023-03-28 Teijin, Mediridge and TFBS Bioscience to Supply Raw Materials for Regenerative Medicine Development and Manufacture Tokyo, Japan, March 28, 2023 --- Teijin Limited, TFBS Bioscience Inc. and Mediridge Co., Ltd. announced today that they have agreed to supply viral vectors and plasmids for cell and gene-therapy products that are used to develop and manufacture regenerative medicines involving gene transfer. Learn more

• Exciting News in GMP Testing Services

  2023-11-26 Exciting News in GMP Testing Services Learn more

• TFBS Bioscience Complete its First Clinical-Grade Manufacturing Batch of Lentiviral Vectors for CAR-T Cell Therapy in Taiwan

  2022-08-17 TFBS Bioscience Complete its First Clinical-Grade Manufacturing Batch of Lentiviral Vectors for CAR-T Cell Therapy in Taiwan - A critical step for TFBS Bioscience to enable the manufacturing of clinical-grade lentiviral vectors in its Taipei facility and ready to supply viral vectors for the global needs of cell and gene therapies Learn more

• Meet TFBS in BIO2022

  2022-05-09 Meet TFBS in BIO2022 TFBS team will be at #BIO2022 in San Diego, June 13-16! (Hall D #3323 in Taiwan Pavilion). Looking forward to catching up in person and making new connections on all! Learn more

• Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc.

  2022-04-29 Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. We are honored to invite the Center for Drug Evaluation (CDE) to visit TFBS Bioscience, Inc. GMP viral vector manufacturing facility. Learn more